Saccharomyces cerevisiae asosida SARS-CoV-2 S1 rekombinant oqsilini olish texnologiyasini o‘rganish
Partner conferences of the International Scientific Journal Research Focus · 30.10.2026 · 1 (8) · 164-166
DOI: 10.66073/refocus-conf/3010041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Partner conferences of the International Scientific Journal Research Focus, online erschienen am 30.10.2026. Verfasst von Toshboyeva Fotima Nuriddin qizi und 2 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This article examines the use of Saccharomyces cerevisiae as an expression system for producing a recombinant SARS-CoV-2 antigen within a subunit vaccine development platform. The study focuses on the pYES2-S1-Zeo construct intended for expression of the SARS-CoV-2 S1 protein in yeast cells. According to the dissertation materials, S. cerevisiae was isolated from baker’s yeast, culture purity was checked microscopically, and a recombinant expression approach was applied. SDS-PAGE and Western blotting were selected for evaluation of recombinant protein expression, with a predicted molecular mass of 61 kDa for S1. The available materials support the study of S. cerevisiae as a recombinant antigen expression platform.
Zitieren
APA
qizi, T. F. N., M.S., A., & o‘g‘li, R. H. T. (2026). Saccharomyces cerevisiae asosida SARS-CoV-2 S1 rekombinant oqsilini olish texnologiyasini o‘rganish. Partner conferences of the International Scientific Journal Research Focus, 1(8), 164-166. https://doi.org/10.66073/refocus-conf/3010041
Vancouver
qizi TFN, M.S. A, o‘g‘li RHT. Saccharomyces cerevisiae asosida SARS-CoV-2 S1 rekombinant oqsilini olish texnologiyasini o‘rganish. Partner conferences of the International Scientific Journal Research Focus. 2026;1(8):164-166. doi:10.66073/refocus-conf/3010041
BibTeX
@article{qizi2026,
author = {qizi, Toshboyeva Fotima Nuriddin and M.S., Ayubov and o‘g‘li, Ravshanov Hamroqul To‘ymurod},
title = {Saccharomyces cerevisiae asosida SARS-CoV-2 S1 rekombinant oqsilini olish texnologiyasini o‘rganish},
journal = {Partner conferences of the International Scientific Journal Research Focus},
year = {2026},
volume = {1},
number = {8},
pages = {164--166},
doi = {10.66073/refocus-conf/3010041}
}
EUVIMED